ESMO Sarcoma and Rare Cancers 2023 | Employing the use of real-world evidence in the study of ultra-rare cancers

Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, provides an overview of his presentation concerning the use of real-world evidence in the context of ultra-rare cancers. Prof. Jones emphasizes that the use of medical registry data relating to the health status of patients may be clinically useful, among other reasons, in defining the natural history of rare diseases and their response rates or prognosis following conventional therapy. This interview took place at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.